JS

Jessica A. Sorrentino

GT G1 Therapeutics: 5 patents #6 of 31Top 20%
GT Gi Therapeutics: 1 patents #6 of 12Top 50%
PA Pharmacosmos Holding A/S: 1 patents #8 of 20Top 40%
📍 Durham, NC: #735 of 4,103 inventorsTop 20%
🗺 North Carolina: #7,471 of 45,564 inventorsTop 20%
Overall (All Time): #680,728 of 4,157,543Top 20%
7
Patents All Time

Issued Patents All Time

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDate
12285431 Treatment of Rb-negative tumors using topoisomerase inhibitors in combination with cyclin dependent kinase 4/6 inhibitors Jay Copeland Strum, John Emerson Bisi, Patrick Joseph Roberts 2025-04-29
11529352 Preservation of immune response during chemotherapy regimens Anne Lai, Jay Copeland Strum, Patrick Joseph Roberts 2022-12-20
11446295 Anti-neoplastic combinations and dosing regimens using CDK4/6 inhibitor compounds to treat Rb-positive tumors Jay Copeland Strum, John Emerson Bisi, Patrick Joseph Roberts, Hannah S. White 2022-09-20
11395821 Treatment of EGFR-driven cancer with fewer side effects Jay Copeland Strum, John Emerson Bisi, Andrew Beelen 2022-07-26
11090306 Treatment of Rb-negative tumors using topoisomerase inhibitors in combination with cyclin dependent kinase 4/6 inhibitors Jay Copeland Strum, John Emerson Bisi, Patrick Joseph Roberts 2021-08-17
10413547 Treatment of Rb-negative tumors using topoisomerase with cyclin dependent kinase 4/6 inhibitors Jay Copeland Strum, John Emerson Bisi, Patrick Joseph Roberts 2019-09-17
10231969 Anti-neoplastic combinations and dosing regimens using CDK4/6 inhibitor compounds to treat RB-positive tumors Jay Copeland Strum, John Emerson Bisi, Patrick Joseph Roberts, Hannah S. White 2019-03-19